LXRX — Lexicon Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Lexicon Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	152	86.7	138	170	238
Net Total Accounts Receivable
Net Total Receivables	0.395	0.014	0.028	1.01	3.47
Total Inventory
Prepaid Expenses
Total Current Assets	158	88.9	141	177	246
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.5	3.48	4.37	7.51	7.32
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	204	137	194	229	298
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	46.8	22.1	23.2	31.5	45.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	47.4	23.3	77.2	136	152
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	156	114	117	93.1	146
Total Liabilities & Shareholders' Equity	204	137	194	229	298
Total Common Shares Outstanding
Total Preferred Shares Outstanding